Clinical Trial Update: A Phase II Study of Moxidex Ophthalmic Solution for Treatment of Marginal Corneal Infiltrates [Phase 2]

View source ↗

Summary

A Phase II clinical trial evaluating Moxidex ophthalmic solution for marginal corneal infiltrates has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Corneal Infiltrates

Drugs mentioned

• Moxidex Ophthalmic Solution

Snippet

Sponsor: Alcon Research | Conditions: Corneal Infiltrates | Phase 2 | Status: TERMINATED